Moneycontrol PRO
divis laboratories
Jump to
738 Results Found
  • Divis Laboratories share price touches 52-week high Aug 31, 2021 09:56 AM IST

    Divis Laboratories share price touches 52-week high

    The company's trailing 12-month (TTM) EPS was at Rs 75.88 per share. (Jun, 2021).

  • Divis Labs Consolidated June 2021 Net Sales at Rs 1,960.64 crore, up 13.3% Y-o-Y Aug 24, 2021 12:22 PM IST

    Divis Labs Consolidated June 2021 Net Sales at Rs 1,960.64 crore, up 13.3% Y-o-Y

  • Buy Divi’s Laboratories; target of Rs 5750: Motilal Oswal Aug 11, 2021 10:08 PM IST

    Buy Divi’s Laboratories; target of Rs 5750: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 5750 in its research report dated August 08, 2021.

  • Divis Labs Consolidated June 2021 Net Sales at Rs 1,960.64 crore, up 13.3% Y-o-Y Aug 10, 2021 10:44 AM IST

    Divis Labs Consolidated June 2021 Net Sales at Rs 1,960.64 crore, up 13.3% Y-o-Y

  • Divis Labs Standalone June 2021 Net Sales at Rs 1,950.16 crore, up 14.05% Y-o-Y Aug 10, 2021 10:22 AM IST

    Divis Labs Standalone June 2021 Net Sales at Rs 1,950.16 crore, up 14.05% Y-o-Y

  • Divis Laboratories reports 13% jump in net profit at Rs 557 crore in Q1 Aug 07, 2021 02:49 PM IST

    Divis Laboratories reports 13% jump in net profit at Rs 557 crore in Q1

    The company had reported a net profit of Rs 492 crore in the April-June quarter of the previous fiscal.

  • Divis Labs Consolidated March 2021 Net Sales at Rs 1,788.19 crore, up 28.67% Y-o-Y Jun 01, 2021 01:11 PM IST

    Divis Labs Consolidated March 2021 Net Sales at Rs 1,788.19 crore, up 28.67% Y-o-Y

  • Divis Labs Standalone March 2021 Net Sales at Rs 1,718.39 crore, up 24.86% Y-o-Y Jun 01, 2021 12:22 PM IST

    Divis Labs Standalone March 2021 Net Sales at Rs 1,718.39 crore, up 24.86% Y-o-Y

  • Buy Divis Laboratories: target of Rs 4810: Sharekhan May 31, 2021 01:40 PM IST

    Buy Divis Laboratories: target of Rs 4810: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4810 in its research report dated May 28, 2021.

  • Buy Divi’s Laboratories; target of Rs 4850: Motilal Oswal May 31, 2021 12:36 PM IST

    Buy Divi’s Laboratories; target of Rs 4850: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 4850 in its research report dated May 30, 2021.

  • What should investors do with Divis Laboratories post Q4 results: buy, sell or hold? May 31, 2021 10:16 AM IST

    What should investors do with Divis Laboratories post Q4 results: buy, sell or hold?

    The company's consolidated profit increased to Rs 502.02 crore in Q4FY21 from Rs 388.23 crore in the corresponding quarter of the last fiscal.

  • Divis Labs Q4 profit jumps 29% to Rs 502 crore on strong operating income, margin May 29, 2021 03:00 PM IST

    Divis Labs Q4 profit jumps 29% to Rs 502 crore on strong operating income, margin

    In the year FY21, the COVID period, consolidated profit surged 44.2 percent to Rs 1,984.29 crore and revenue grew by 29.2 percent to Rs 6,969.4 crore compared to the previous year.

  • Buy Divis Laboratories: target of Rs 4500: Sharekhan Mar 24, 2021 03:40 PM IST

    Buy Divis Laboratories: target of Rs 4500: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4500 in its research report dated March 23, 2021.

  • Gladiator Stocks - Divis Laboratories: ICICI Direct Mar 22, 2021 03:05 PM IST

    Gladiator Stocks - Divis Laboratories: ICICI Direct

    According to ICICI Direct, Buy Divis Laboratories in the range of Rs 3280.00–3325.00 for target price of Rs 3740.00 with a stop loss of Rs 3110.00. Time Frame: Six months.

  • Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y Mar 05, 2021 10:57 AM IST

    Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y

  • Buy Divi’s Laboratories; target of Rs 4440: ICICI Direct Feb 10, 2021 03:30 PM IST

    Buy Divi’s Laboratories; target of Rs 4440: ICICI Direct

    ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 4440 in its research report dated February 06, 2021.

  • Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y Feb 09, 2021 10:00 AM IST

    Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y

  • Divis Labs Standalone December 2020 Net Sales at Rs 1,656.48 crore, up 19.13% Y-o-Y Feb 09, 2021 09:22 AM IST

    Divis Labs Standalone December 2020 Net Sales at Rs 1,656.48 crore, up 19.13% Y-o-Y

  • Buy Divi's Laboratories; target of Rs 4425: ICICI Direct Dec 30, 2020 12:42 PM IST

    Buy Divi's Laboratories; target of Rs 4425: ICICI Direct

    ICICI Securities is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4425 in its research report dated December 30, 2020.

  • Divi's Laboratories shares climb 3%; stock crosses Rs 1 lakh crore m-cap mark Dec 17, 2020 11:46 AM IST

    Divi's Laboratories shares climb 3%; stock crosses Rs 1 lakh crore m-cap mark

    The pharma sector has been among the top beneficiaries of the COVID-19 pandemic and the stock of Divi's has been among the top performers of the pharma pack.

  • Buy Divis Laboratories: target of Rs 4175: Sharekhan Dec 07, 2020 02:02 PM IST

    Buy Divis Laboratories: target of Rs 4175: Sharekhan

    Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 4175 in its research report dated December 04, 2020.

  • Buy Divis Laboratories: target of Rs 3800: Sharekhan Nov 11, 2020 11:30 AM IST

    Buy Divis Laboratories: target of Rs 3800: Sharekhan

    Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 3800 in its research report dated November 06, 2020.

  • Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal Nov 10, 2020 12:12 PM IST

    Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3900 in its research report dated November 08, 2020.

  • Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market Nov 09, 2020 01:38 PM IST

    Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market

    Dolat Capital Market recommended accumulate rating on Divi's Laboratories with a target price of Rs 3515 in its research report dated November 08, 2020.

  • Buy Divi's Laboratories; target of Rs 4205: ICICI Direct Nov 09, 2020 11:52 AM IST

    Buy Divi's Laboratories; target of Rs 4205: ICICI Direct

    ICICI Direct is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4205 in its research report dated November 08, 2020.

Sections
ISO 27001 - BSI Assurance Mark